A 40-year-old man with type 2 diabetes is switched to pioglitazone. What is the primary mechanism of action of this drug?

• A. Blockade of ATP-sensitive potassium channels
• B. Increased insulin synthesis
• C. Increased insulin uptake by muscle and adipose tissue
• D. Stimulation of the peroxisome proliferator-activated receptor gamma

Answer: (D)

Pioglitazone is classified as a thiazolidinedione, and its primary mechanism of action involves the stimulation of peroxisome proliferator-activated receptor gamma (PPAR-γ). This receptor is a type of nuclear regulatory protein that plays a critical role in glucose and lipid metabolism. When pioglitazone binds to PPAR-γ, it leads to increased transcription of genes that regulate glucose and lipid pathways. This results in enhanced insulin sensitivity, particularly in muscle and adipose tissues, which subsequently helps to improve glycemic control in patients with type 2 diabetes.

Stimulation of PPAR-γ also leads to an increase in adiponectin levels and promotes fatty acid storage and glucose uptake, further contributing to its effect on insulin sensitivity. Therefore, the correct answer encapsulates the fundamental mechanism by which pioglitazone operates to exert its therapeutic effects in managing type 2 diabetes.